Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 2500 of 3173 entries
View as:

Safety Study of Continued Enzalutamide Treatment In Prostate Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT01995513 Org: User:
Start: 10/22/13 End: 08/31/22 Due: 08/31/23

Study Evaluating The SBI-087 In Subjects With Systemic Lupus Erythematosus

Phase: N/A Priority: Normal
NCT ID: NCT00714116 Org: User:
Start: 03/31/09 End: 09/30/12 Due: 09/30/13

A Study to Describe the Safety of a Vaccine (Called 13vPnC) in Healthy People 18 to 49 Years of Age in India

Phase: N/A Priority: Normal
NCT ID: NCT05329259 Org: User:
Start: 10/06/22 End: 11/30/22 Due: 11/30/23

A Study of the Efficacy and Safety of Aricept in Patients With Severe Alzheimer's Disease Who Are Living in Skilled Nursing Homes

Phase: N/A Priority: Normal
NCT ID: NCT00630851 Org: User:
Start: 10/31/02 End: 10/31/04 Due: 10/31/05

Acute Cough Study In Children

Phase: N/A Priority: Normal
NCT ID: NCT01257542 Org: User:
Start: 12/31/10 End: 03/31/11 Due: 03/31/12

CMA-676 in Treating Patients With Acute Myeloid Leukemia in First Relapse

Phase: N/A Priority: Normal
NCT ID: NCT00003131 Org: User:
Start: 02/28/97 End: 02/28/02 Due: 02/28/03

Study On Fatigue- And Hand-Foot Syndrome-Related Quality Of Life In Patients With Metastatic Renal Cell Carcinoma Receiving A Tyrosine Kinase Inhibitor as First-Line Treatment

Phase: N/A Priority: Normal
NCT ID: NCT02789137 Org: User:
Start: 12/22/16 End: 10/20/20 Due: 10/20/21

Urodynamic Effects of UK-369,003 in Men With Lower Urinary Tract Symptoms

Phase: N/A Priority: Normal
NCT ID: NCT00408954 Org: User:
Start: 03/31/07 End: 06/30/08 Due: 06/30/09

A Clinical Trial to Learn About the Study Medicine Called Maplirpacept (PF-07901801), Alone and When Used in Combination With Other Medicines to Treat Participants With Advanced Hematological Malignancies, Including Lymphoma, Leukemia and Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT03530683 Org: User:
Start: 05/14/18 End: 07/18/24 Due: 07/18/25

A Study Of Combined C- MET Inhibitor And PAN-HER Inhibitor (PF-02341066 And PF-00299804) In Patients With Non- Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01121575 Org: User:
Start: 08/31/10 End: 02/28/14 Due: 02/28/15

Single Dose Study to Assess the Safety, Tolerability and Pharmacokinetics(PK) of PF-06865571

Phase: N/A Priority: Normal
NCT ID: NCT03092232 Org: User:
Start: 03/16/17 End: 07/17/17 Due: 07/17/18

Retrospective Study on Referral Patterns for High Risk Patients Post Nephrectomy

Phase: N/A Priority: Normal
NCT ID: NCT04309617 Org: User:
Start: 07/31/19 End: 04/28/20 Due: 04/28/21

Study To Assess The Efficacy And Safety Of Pf-06651600 In Subjects With Rheumatoid Arthritis With An Inadequate Response To Methotrexate

Phase: N/A Priority: Normal
NCT ID: NCT02969044 Org: User:
Start: 12/20/16 End: 12/12/17 Due: 12/12/18

Neuromuscular Changes In Small For Gestational Age Children During Somatropin Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00625872 Org: User:
Start: 07/31/08 End: 03/31/11 Due: 03/31/12

A Study to Learn About the Effectiveness of Cancer Medicines in Patients With Metastatic Non-small Cell Lung Cancer in Norway.

Phase: N/A Priority: Normal
NCT ID: NCT05834348 Org: User:
Start: 06/23/23 End: 01/23/24 Due: 01/23/25

Study Of The Safety Of CE 224,545 And Methotrexate In Patients With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT00446784 Org: User:
Start: 04/30/07 End: 08/31/07 Due: 08/31/08

Study To Evaluate Safety And Efficacy Of PF-06700841 In Subjects With Moderate To Severe Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT02969018 Org: User:
Start: 12/31/16 End: 03/31/18 Due: 03/31/19

Efficacy Of Pf-04531083 In Treating Post-Surgical Dental Pain

Phase: N/A Priority: Normal
NCT ID: NCT01512160 Org: User:
Start: 10/31/11 End: 05/31/12 Due: 05/31/13

Effect Of Ketoconazole On The Pharmacokinetics Of Tasocitinib (CP-690,550) In Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01202240 Org: User:
Start: 09/30/10 End: 09/30/10 Due: 09/30/11

A Study To Estimate The Relative Bioavailability Of PF-00258210 Administered Alone Or In Combination With PF-00610355

Phase: N/A Priority: Normal
NCT ID: NCT01043276 Org: User:
Start: 01/31/10 End: 04/30/10 Due: 04/30/11

A Study to Learn About the Safety and Immune Response of 20vPnC in Adults in India.

Phase: N/A Priority: Normal
NCT ID: NCT05875727 Org: User:
Start: 08/16/23 End: 10/02/23 Due: 10/02/24

Bioequivalence (BE) Study Comparing Fluconazole 150mg Capsule Manufactured in China and in France

Phase: N/A Priority: Normal
NCT ID: NCT03621072 Org: User:
Start: 06/03/19 End: 07/20/19 Due: 07/20/20

Study Of The Effect Of Fragmin In The Treatment Of Neuroischaemic Foot Ulcers In Diabetic Patients

Phase: N/A Priority: Normal
NCT ID: NCT00662831 Org: User:
Start: 04/30/08 End: 10/31/10 Due: 10/31/11

A Study Of PF-06664178 In Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02122146 Org: User:
Start: 08/31/14 End: 06/30/16 Due: 06/30/17

A Study to Learn About the Medicine (PF-07321332 or Nirmatrelvir/Ritonavir) in Healthy Lactating Women

Phase: N/A Priority: Normal
NCT ID: NCT05441215 Org: User:
Start: 12/12/22 End: 12/15/23 Due: 12/15/24